Summit Therapeutics (SMMT) Stock Price & Financial Analysis
Summit Therapeutics Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About Summit Therapeutics
What is the current stock price for SMMT?
As of the latest trading session, SMMT stock trades at $14.25. The 52-week range is $12.55–$30.98, with a day range of $14.17–$14.76.
What is the P/E ratio for SMMT?
The P/E ratio (Price-to-Earnings) for SMMT is shown in the Key Statistics section. This valuation metric helps compare Summit Therapeutics Inc. to industry peers.
Does SMMT pay dividends?
Summit Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for SMMT?
Based on 9 analysts, the consensus for SMMT is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.
What is the market cap of SMMT?
Summit Therapeutics's market capitalization is $11.05B, classifying it as a large-cap company. Summit Therapeutics operates in the Healthcare sector within the Biotechnology industry.